Home Medicine Quantification of adult T-cell leukemia/lymphoma cells using simple four-color flow cytometry
Article
Licensed
Unlicensed Requires Authentication

Quantification of adult T-cell leukemia/lymphoma cells using simple four-color flow cytometry

  • Tomohiro Ishigaki EMAIL logo , Yuji Zaike , Masanori Nojima , Seiichiro Kobayashi , Nobuhiro Ohno , Kaoru Uchimaru , Arinobu Tojo , Hiromitsu Nakauchi and Nobukazu Watanabe
Published/Copyright: July 23, 2014

Abstract

Background: The absolute number of adult T-cell leukemia/lymphoma (ATL) cells in peripheral blood is an essential indicator to evaluate disease status. However, microscopically counting ATL cells based on morphology requires experience and tends to be inaccurate due to the rarity of ATL.

Methods: Based on our research showing that acute-type ATL cells are specifically enriched in the CD4+/CD7- (CD7N) fraction, a new analytical method to accurately quantify ATL cells was established using an internal bead standard and simple four-color flow cytometry. This method was verified by comparison with microscopic examination of 49 peripheral blood samples and used to follow up patients.

Results: A strong correlation was observed between the number of CD7N cells measured by flow cytometry and the number of abnormal lymphocytes measured microscopically by experienced technicians [Pearson’s R, 0.963; Spearman’s rho, 0.921; intercorrelation coefficient, 0.962]. The linear regression coefficient was close to 1 (β=1.013). Our method could detect 1 cell/μL, and the limit of quantitation was between 2.9 and 9.8 cells/μL. The frequency of CD7N cells among CD4+ cells changed during chemotherapy, which reflected differences between chemosensitive and chemoresistant cases. Kaplan-Meier analysis with a log-rank test showed that patients with decreased CD7N proportion after chemotherapy had significantly longer disease-specific survival (p=0.003).

Conclusions: Our newly established method quantified tumor cells in patients with acute-type ATL. Furthermore, this method was useful for assessing the efficacy of chemotherapy, and the change of the CD7N proportion could be more important to predict prognosis.


Corresponding author: Tomohiro Ishigaki, Clinical FACS Core Laboratory, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan, Phone: +81 3 5449 5765, Fax: +81 3 5449 5750, E-mail: ; Institute of Medical Science, Division of Stem Cell Therapy, University of Tokyo, Tokyo, Japan

Acknowledgments

We would like to thank Dr. Naoki Oyaizu and Dr. Naoyuki Isoo (Laboratory Medicine, Research Hospital, Institute of Medical science) for their kind permission to introduce this clinical test, as well as Mr. Yukihisa Tanaka, Ms. Etsuko Nagai, and Ms. Motoko Mizukami for their excellent morphological classification.

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Financial support: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984–87). Br J Haematol 1991;79:428–37.Search in Google Scholar

2. Ohshima K. Pathological features of diseases associated with human T-cell leukemia virus type I. Cancer Sci 2007;98:772–8.10.1111/j.1349-7006.2007.00456.xSearch in Google Scholar PubMed

3. de Souza JG, Fonseca FG, Martins-Filho OA, Teixeira-Carvalho A, Martins CP, Carvalho LD, et al. Diagnostic tool based on an HTLV-1-Tax expression system in eukaryotic cells using a poxvirus vector. J Virol Methods 2010;166:65–71.10.1016/j.jviromet.2010.02.021Search in Google Scholar PubMed

4. Sadamori N. Clinical and biological significance of serum tumor markers in adult T-cell leukemia. Leuk Lymphoma 1996;22:415–9.10.3109/10428199609054779Search in Google Scholar PubMed

5. Kamihira S, Dateki N, Sugahara K, Hayashi T, Harasawa H, Minami S, et al. Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count. Clin Lab Haematol 2003;25:111–7.10.1046/j.1365-2257.2003.00503.xSearch in Google Scholar PubMed

6. Waters A, Oliveira AL, Coughlan S, de Venecia C, Schor D, Leite AC, et al. Multiplex real-time PCR for the detection and quantitation of HTLV-1 and HTLV-2 proviral load: addressing the issue of indeterminate HTLV results. J Clin Virol 2011;52:38–44.10.1016/j.jcv.2011.05.022Search in Google Scholar PubMed

7. Moens B, Lopez G, Adaui V, Gonzalez E, Kerremans L, Clark D, et al. Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination. J Clin Microbiol 2009;47:3682–91.10.1128/JCM.00781-09Search in Google Scholar PubMed PubMed Central

8. Takenouchi H, Umeki K, Sasaki D, Yamamoto I, Nomura H, Takajo I, et al. Defective human T-lymphotropic virus type 1 provirus in asymptomatic carriers. Int J Cancer 2011;128: 1335–43.10.1002/ijc.25450Search in Google Scholar PubMed

9. Altamirano NA, Rocco C, Aulicino P, Sen L, Mangano A. Quantitation of HTLV-I proviral load by a real-time PCR assay using SYBR Green: comparison of two methods for DNA isolation. J Virol Methods 2010;170:160–4.10.1016/j.jviromet.2010.08.021Search in Google Scholar PubMed

10. Kamihira S, Yamano Y, Iwanaga M, Sasaki D, Satake M, Okayama A, et al. Intra- and inter-laboratory variability in human T-cell leukemia virus type-1 proviral load quantification using real-time polymerase chain reaction assays: a multi-center study. Cancer Sci 2010;101:2361–7.10.1111/j.1349-7006.2010.01720.xSearch in Google Scholar PubMed

11. Tian Y, Kobayashi S, Ohno N, Isobe M, Tsuda M, Zaike Y, et al. Leukemic T cells are specifically enriched in a unique CD3(dim) CD7(low) subpopulation of CD4(+) T cells in acute-type adult T-cell leukemia. Cancer Sci 2011;102:569–77.10.1111/j.1349-7006.2010.01833.xSearch in Google Scholar PubMed

12. Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W Jr., et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 2009;27:453–9.10.1200/JCO.2008.18.2428Search in Google Scholar PubMed PubMed Central

13. Kobayashi S, Tian Y, Ohno N, Yuji K, Ishigaki T, Isobe M, et al. The CD3 versus CD7 plot in multicolor flow cytometry reflects progression of disease stage in patients infected with HTLV-I. PLoS One 2013;8:e53728.10.1371/journal.pone.0053728Search in Google Scholar PubMed PubMed Central

14. Shao H, Yuan CM, Xi L, Raffeld M, Morris JC, Janik JE, et al. Minimal residual disease detection by flow cytometry in adult T-cell leukemia/lymphoma. Am J Clin Pathol 2010;133:592–601.10.1309/AJCPS1K0OHLJYWWVSearch in Google Scholar PubMed PubMed Central

15. Borowitz MJ, Guenther KL, Shults KE, Stelzer GT. Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol 1993;100:534–40.10.1093/ajcp/100.5.534Search in Google Scholar PubMed

16. Weil R, Levraud JP, Dodon MD, Bessia C, Hazan U, Kourilsky P, et al. Altered expression of tyrosine kinases of the Src and Syk families in human T-cell leukemia virus type 1-infected T-cell lines. J Virol 1999;73:3709–17.10.1128/JVI.73.5.3709-3717.1999Search in Google Scholar PubMed PubMed Central

17. Schnizlein-Bick CT, Spritzler J, Wilkening CL, Nicholson JK, O’Gorman MR. Evaluation of TruCount absolute-count tubes for determining CD4 and CD8 cell numbers in human immunodeficiency virus-positive adults. Site Investigators and The NIAID DAIDS New Technologies Evaluation Group. Clin Diagn Lab Immunol 2000;7:336–43.10.1128/CDLI.7.3.336-343.2000Search in Google Scholar PubMed PubMed Central

18. Motoi T, Uchiyama T, Uchino H, Ueda R, Araki K. Serum soluble interleukin-2 receptor levels in patients with adult T-cell leukemia and human T-cell leukemia/lymphoma virus type-I seropositive healthy carriers. Jpn J Cancer Res 1988;79:593–9.10.1111/j.1349-7006.1988.tb00028.xSearch in Google Scholar PubMed PubMed Central

19. Araki K, Harada K, Nakamoto K, Shiroma M, Miyakuni T. Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers. Clin Exp Immunol 2000;119:259–63.10.1046/j.1365-2249.2000.01136.xSearch in Google Scholar PubMed PubMed Central

20. Leblond V, Othman TB, Blanc C, Theodorou I, Choquet S, Sutton L, et al. Expansion of CD4+CD7- T cells, a memory subset with preferential interleukin-4 production, after bone marrow transplantation. Transplantation 1997;64:1453–9.10.1097/00007890-199711270-00014Search in Google Scholar PubMed


Supplemental Material

The online version of this article (DOI: DOI:10.1515/cclm-2014-0183) offers supplementary material, available to authorized users.


Received: 2014-2-19
Accepted: 2014-6-18
Published Online: 2014-7-23
Published in Print: 2015-1-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Harmonisation of specialist training and continuing professional development in laboratory medicine: a long but necessary journey
  4. Reviews
  5. Laboratory medicine in the European Union
  6. Role of leptin in female reproduction
  7. Mini Review
  8. Interrelatedness between C-reactive protein and oxidized low-density lipoprotein
  9. General Clinical Chemistry and Laboratory Medicine
  10. Comparison of approaches and measurement of continuing professional development for specialists in laboratory medicine within four European countries
  11. Point-of-care urine albumin in general practice offices: effect of participation in an external quality assurance scheme
  12. Triple positive antiphospholipid antibody profile in outpatients with tests for lupus anticoagulants
  13. Effects of cigarette smoking on circulating leukocytes and plasma cytokines in monozygotic twins
  14. Proteolysis is a confounding factor in the interpretation of faecal calprotectin
  15. Urinary neutrophil gelatinase-associated lipocalin and clinical outcomes in chronic kidney disease patients
  16. Cancer Diagnostics
  17. Quantification of adult T-cell leukemia/lymphoma cells using simple four-color flow cytometry
  18. Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development
  19. Cardiovascular Diseases
  20. Increased serum homocitrulline concentrations are associated with the severity of coronary artery disease
  21. S100B concentrations increase perioperatively in jugular vein blood despite limited metabolic and inflammatory response to clinically uneventful carotid endarterectomy
  22. Long-term biological variability of galectin-3 after heart transplantation
  23. Diabetes
  24. Evaluation of a next generation direct whole blood enzymatic assay for hemoglobin A1c on the ARCHITECT c8000 chemistry system
  25. The 13C-glucose breath test is a valid non-invasive screening tool to identify metabolic syndrome in adolescents
  26. Comparison of a direct enzymatic assay and polyacrylamide tube gel electrophoresis for measurement of small, dense low-density lipoprotein cholesterol
  27. Letters to the Editor
  28. Comparison of Abbott Architect high-sensitivity troponin I in Rapid Serum Tubes and plasma
  29. Can EDTA, EDTA-fluoride, and buffered citrate tubes be used for measurement of HbA1c on the Bio-Rad D10?
  30. How to reduce EDTA contamination in laboratory specimens: a Tunisian experience
  31. Does mean platelet volume share any relationship with biochemical and hematological parameters?
  32. Association of retrospective markers of glycemia and the use of continuous glucose monitoring in white adults with type 2 diabetes mellitus – a preliminary report
  33. Operative performances and efficiency for infectious disease testing of two immunochemistry analyzers – Abbott ARCHITECT i2000SR and DiaSorin Liaison XL
Downloaded on 13.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2014-0183/html
Scroll to top button